An insurer, or a pharmacy benefits manager acting for it, may not set requirements, exclusions, payment terms or other conditions on a covered entity or contract pharmacy that differ from those for others on the ground that it is one or dispenses 340B drugs. It may not interfere with a person's choice of such a pharmacy.
Bill
HB 1162
Act
Acts 2022, ch. 319
Session
2022
Signed
11 April 2022
Applies to
Health insurers and pharmacy benefits managers
Limits
Hospitals are outside the act's meaning of covered entity. The first rule does not cover drugs that cost more than $250,000 a year for a patient. A later version of the section takes effect July 1, 2027.
Impose requirements, exclusions, reimbursement terms, or other conditions on a covered entity or contract pharmacy that differ from those applied to entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses 340B-covered drugs
The Secretary of Health and Human Resources convenes a work group to evaluate the effects of the 340B program in Virginia and reports to the chairs of named Senate and House committees by November 1, 2026.
Session
2026
Applies to
The Secretary of Health and Human Resources
Limits
Sets no rule for manufacturers, insurers or clinics.
shall convene a stakeholder work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth
Plain-language summaries, not legal advice. Laws change, and court rulings on them are not covered here. Read the state’s own page before you rely on one.